Objective: The efficacy and tolerability of acarbose were examined in a postmarketing surveillance study of 27,803 patients with diabetes mellitus ... of a new drug. On the other hand, a ...

As expected, type 1 patients were younger, had a lower mean body mass index, and had a longer mean diabetes duration ... concomitant medication was received by 81% of acarbose and 86% of placebo ...

Synex Medical just raised $21.8 million to build a portable MRI capable of testing glucose and other important molecules ...

If you've recently received a diagnosis of type 2 diabetes, understanding your treatment options is an important first step.

Acarbose does not usually cause low blood sugar . Low blood sugar may occur if this drug is prescribed with other diabetes medications, or if you do not consume enough calories from food ...

Are you searching for medications to treat 'Diabetes'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Diabetes. The page includes both the ...

Discover all the brand names or Trade names of generic drug called Acarbose. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to comprehend ...

Prediabetes, often considered the step before diabetes, is when you have higher than usual blood glucose (blood sugar) levels ...

At least a quarter of people who diagnosed with diabetes get the medical care, including drugs, that are proved effective. Diabetes also raises the risk for a host of other problems. These include ...

Which type 2 diabetes treatment is right for you? If lifestyle changes alone don’t allow you to meet your blood sugar and A1C goals, your doctor may prescribe medication. Here are some factors ...

Your donation makes it possible for us to keep doing this important work, keeping you informed every step of the way to the November election Medication used to treat type 2 diabetes has been ...

A specific type of diabetes medication has been associated with a lower risk of dementia, Alzheimer's and Parkinson's disease in a study published today. The South Korean study followed 358,862 ...